Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model. FE [Internet]. 2018 Jan. 30 [cited 2025 Oct. 29];19(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1328